Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Journal of Thoracic Oncology, 06/22/2012
Lagerwaard FJ et al. – Patients referred for stereotactic ablative radiotherapy (SABR) have substantially worse baseline health–related quality of life (HRQOL) scores than those reported in the surgical literature. Clinically relevant deteriorations in HRQOL subscale scores were not observed after SABR.